Cancer Clinical Trial Participation
Witnesses testified regarding cancer treatment and clinical trials. Among the issues addressed were cancer prevention,…
Food and Drug Administration Announcement
2001-05-10T20:29:35-04:00https://images.c-span.org/defaults/capitol.jpgSecretary Thompson and others spoke to reporters following Food and Drug Administration approval of the cancer-fighting drug Gleevec. They said that a study involving leukemia patients had shown that the drug effectively targeted tumors at the molecular level. Following their remarks they answered questions from the reporters.Secretary Thompson and others spoke to reporters following Food and Drug Administration approval of the cancer-fighting drug Gleevec. They… read more
Food and Drug Administration Announcement Secretary Thompson and others spoke to reporters following Food and Drug Administration approval of the cancer-fighting drug Gleevec. They said that a study involving leukemia patients had shown that the drug effectively targeted tumors at the molecular level. Following their remarks they answered questions from the reporters. close
People in this video
- Susan Dreger Patient
- Richard Klausner Director National Cancer Institute
- Richard Pazdur M.D. Official U.S. Food and Drug Administration
- Tommy Thompson Secretary Wisconsin
- Daniel Vasella President Novartis Pharmaceuticals Corporation
Hosting Organization
- Department of Health and Human ServicesDepartment of Health and Human Services
Related Video
-
-
Cancer Drug Review Process
Secretary Thompson and health experts talked with reporters about cancer drugs and their reviewing process. The…
-
Breast Cancer Issues
Witnesses testified about medical research, prevention and treatment of breast cancer. They also talked about proposed…
-
Future of Cancer Treatment
Dr. Freeman is chairman of the President’s Cancer Panel, an advisory group established by Congress that reports…